🇺🇸 FDA
Patent

US 12279630

Treatment and prevention of seed allergies

granted A61KA61K36/48A61K36/52

Quick answer

US patent 12279630 (Treatment and prevention of seed allergies) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K36/48, A61K36/52, A61K39/35, A61K49/0004